世界のポンペ病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pompe Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4700
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、ポンペ病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（乳児発症ポンペ病、成人発症ポンペ病）、用途別市場規模（病院、医療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・ポンペ病治療の市場動向
・企業の競争状況、市場シェア
・ポンペ病治療の種類別市場規模（乳児発症ポンペ病、成人発症ポンペ病）
・ポンペ病治療の用途別市場規模（病院、医療センター、その他）
・ポンペ病治療の北米市場規模2016-2027（アメリカ、カナダ）
・ポンペ病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・ポンペ病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ポンペ病治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ポンペ病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Amicus Therapeutics、Audentes Therapeutics、Sanofi Genzyme、EpiVax、Oxyrane、Sangamo BioSciences、Valerion Therapeutics）
・結論

Pompe disease is a rare disease, also known as acid maltase deficiency (AMD) or glycogen storage disorder (GSD).Glycogenosis II is also called “glycogenosis type 2”.
The availability of reimbursement policies for the treatment Pompe disease as one of the primary factors that will have a positive impact on the growth of this market.

Market Analysis and Insights: Global Pompe Disease Treatment Market
The global Pompe Disease Treatment market size is projected to reach US$ 1093.5 million by 2026, from US$ 945.2 million in 2019, at a CAGR of 2.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pompe Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pompe Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pompe Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pompe Disease Treatment market.

Global Pompe Disease Treatment Scope and Market Size
Pompe Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pompe Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Infantile-Onset Pompe Disease
Adult-Onset Pompe Disease

Segment by Application
Hospital
Medical Center
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amicus Therapeutics
Audentes Therapeutics
Sanofi Genzyme
EpiVax
Oxyrane
Sangamo BioSciences
Valerion Therapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pompe Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Infantile-Onset Pompe Disease
1.2.3 Adult-Onset Pompe Disease
1.3 Market by Application
1.3.1 Global Pompe Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Medical Center
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pompe Disease Treatment Market Perspective (2016-2027)
2.2 Pompe Disease Treatment Growth Trends by Regions
2.2.1 Pompe Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pompe Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Pompe Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Pompe Disease Treatment Industry Dynamic
2.3.1 Pompe Disease Treatment Market Trends
2.3.2 Pompe Disease Treatment Market Drivers
2.3.3 Pompe Disease Treatment Market Challenges
2.3.4 Pompe Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pompe Disease Treatment Players by Revenue
3.1.1 Global Top Pompe Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Pompe Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Pompe Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pompe Disease Treatment Revenue
3.4 Global Pompe Disease Treatment Market Concentration Ratio
3.4.1 Global Pompe Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pompe Disease Treatment Revenue in 2020
3.5 Pompe Disease Treatment Key Players Head office and Area Served
3.6 Key Players Pompe Disease Treatment Product Solution and Service
3.7 Date of Enter into Pompe Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pompe Disease Treatment Breakdown Data by Type
4.1 Global Pompe Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Pompe Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Pompe Disease Treatment Breakdown Data by Application
5.1 Global Pompe Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Pompe Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pompe Disease Treatment Market Size (2016-2027)
6.2 North America Pompe Disease Treatment Market Size by Type
6.2.1 North America Pompe Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Pompe Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Pompe Disease Treatment Market Size by Type (2016-2027)
6.3 North America Pompe Disease Treatment Market Size by Application
6.3.1 North America Pompe Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Pompe Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Pompe Disease Treatment Market Size by Application (2016-2027)
6.4 North America Pompe Disease Treatment Market Size by Country
6.4.1 North America Pompe Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Pompe Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Pompe Disease Treatment Market Size (2016-2027)
7.2 Europe Pompe Disease Treatment Market Size by Type
7.2.1 Europe Pompe Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Pompe Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Pompe Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Pompe Disease Treatment Market Size by Application
7.3.1 Europe Pompe Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Pompe Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Pompe Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Pompe Disease Treatment Market Size by Country
7.4.1 Europe Pompe Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Pompe Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pompe Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Pompe Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Pompe Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pompe Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pompe Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Pompe Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Pompe Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pompe Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pompe Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Pompe Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Pompe Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pompe Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pompe Disease Treatment Market Size (2016-2027)
9.2 Latin America Pompe Disease Treatment Market Size by Type
9.2.1 Latin America Pompe Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Pompe Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Pompe Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Pompe Disease Treatment Market Size by Application
9.3.1 Latin America Pompe Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Pompe Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Pompe Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Pompe Disease Treatment Market Size by Country
9.4.1 Latin America Pompe Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Pompe Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pompe Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Pompe Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Pompe Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pompe Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pompe Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Pompe Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Pompe Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pompe Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pompe Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Pompe Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Pompe Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pompe Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amicus Therapeutics
11.1.1 Amicus Therapeutics Company Details
11.1.2 Amicus Therapeutics Business Overview
11.1.3 Amicus Therapeutics Pompe Disease Treatment Introduction
11.1.4 Amicus Therapeutics Revenue in Pompe Disease Treatment Business (2016-2021)
11.1.5 Amicus Therapeutics Recent Development
11.2 Audentes Therapeutics
11.2.1 Audentes Therapeutics Company Details
11.2.2 Audentes Therapeutics Business Overview
11.2.3 Audentes Therapeutics Pompe Disease Treatment Introduction
11.2.4 Audentes Therapeutics Revenue in Pompe Disease Treatment Business (2016-2021)
11.2.5 Audentes Therapeutics Recent Development
11.3 Sanofi Genzyme
11.3.1 Sanofi Genzyme Company Details
11.3.2 Sanofi Genzyme Business Overview
11.3.3 Sanofi Genzyme Pompe Disease Treatment Introduction
11.3.4 Sanofi Genzyme Revenue in Pompe Disease Treatment Business (2016-2021)
11.3.5 Sanofi Genzyme Recent Development
11.4 EpiVax
11.4.1 EpiVax Company Details
11.4.2 EpiVax Business Overview
11.4.3 EpiVax Pompe Disease Treatment Introduction
11.4.4 EpiVax Revenue in Pompe Disease Treatment Business (2016-2021)
11.4.5 EpiVax Recent Development
11.5 Oxyrane
11.5.1 Oxyrane Company Details
11.5.2 Oxyrane Business Overview
11.5.3 Oxyrane Pompe Disease Treatment Introduction
11.5.4 Oxyrane Revenue in Pompe Disease Treatment Business (2016-2021)
11.5.5 Oxyrane Recent Development
11.6 Sangamo BioSciences
11.6.1 Sangamo BioSciences Company Details
11.6.2 Sangamo BioSciences Business Overview
11.6.3 Sangamo BioSciences Pompe Disease Treatment Introduction
11.6.4 Sangamo BioSciences Revenue in Pompe Disease Treatment Business (2016-2021)
11.6.5 Sangamo BioSciences Recent Development
11.7 Valerion Therapeutics
11.7.1 Valerion Therapeutics Company Details
11.7.2 Valerion Therapeutics Business Overview
11.7.3 Valerion Therapeutics Pompe Disease Treatment Introduction
11.7.4 Valerion Therapeutics Revenue in Pompe Disease Treatment Business (2016-2021)
11.7.5 Valerion Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pompe Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Infantile-Onset Pompe Disease
Table 3. Key Players of Adult-Onset Pompe Disease
Table 4. Global Pompe Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pompe Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pompe Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pompe Disease Treatment Market Share by Regions (2016-2021)
Table 8. Global Pompe Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pompe Disease Treatment Market Share by Regions (2022-2027)
Table 10. Pompe Disease Treatment Market Trends
Table 11. Pompe Disease Treatment Market Drivers
Table 12. Pompe Disease Treatment Market Challenges
Table 13. Pompe Disease Treatment Market Restraints
Table 14. Global Pompe Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pompe Disease Treatment Market Share by Players (2016-2021)
Table 16. Global Top Pompe Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pompe Disease Treatment as of 2020)
Table 17. Ranking of Global Top Pompe Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pompe Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pompe Disease Treatment Product Solution and Service
Table 21. Date of Enter into Pompe Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pompe Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Pompe Disease Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Pompe Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Pompe Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Pompe Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pompe Disease Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Pompe Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pompe Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pompe Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Pompe Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Pompe Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pompe Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pompe Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pompe Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pompe Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Pompe Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Pompe Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pompe Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pompe Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pompe Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pompe Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pompe Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pompe Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pompe Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pompe Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pompe Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pompe Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Pompe Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Pompe Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pompe Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pompe Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pompe Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pompe Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pompe Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pompe Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pompe Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pompe Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pompe Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Amicus Therapeutics Company Details
Table 62. Amicus Therapeutics Business Overview
Table 63. Amicus Therapeutics Pompe Disease Treatment Product
Table 64. Amicus Therapeutics Revenue in Pompe Disease Treatment Business (2016-2021) & (US$ Million)
Table 65. Amicus Therapeutics Recent Development
Table 66. Audentes Therapeutics Company Details
Table 67. Audentes Therapeutics Business Overview
Table 68. Audentes Therapeutics Pompe Disease Treatment Product
Table 69. Audentes Therapeutics Revenue in Pompe Disease Treatment Business (2016-2021) & (US$ Million)
Table 70. Audentes Therapeutics Recent Development
Table 71. Sanofi Genzyme Company Details
Table 72. Sanofi Genzyme Business Overview
Table 73. Sanofi Genzyme Pompe Disease Treatment Product
Table 74. Sanofi Genzyme Revenue in Pompe Disease Treatment Business (2016-2021) & (US$ Million)
Table 75. Sanofi Genzyme Recent Development
Table 76. EpiVax Company Details
Table 77. EpiVax Business Overview
Table 78. EpiVax Pompe Disease Treatment Product
Table 79. EpiVax Revenue in Pompe Disease Treatment Business (2016-2021) & (US$ Million)
Table 80. EpiVax Recent Development
Table 81. Oxyrane Company Details
Table 82. Oxyrane Business Overview
Table 83. Oxyrane Pompe Disease Treatment Product
Table 84. Oxyrane Revenue in Pompe Disease Treatment Business (2016-2021) & (US$ Million)
Table 85. Oxyrane Recent Development
Table 86. Sangamo BioSciences Company Details
Table 87. Sangamo BioSciences Business Overview
Table 88. Sangamo BioSciences Pompe Disease Treatment Product
Table 89. Sangamo BioSciences Revenue in Pompe Disease Treatment Business (2016-2021) & (US$ Million)
Table 90. Sangamo BioSciences Recent Development
Table 91. Valerion Therapeutics Company Details
Table 92. Valerion Therapeutics Business Overview
Table 93. Valerion Therapeutics Pompe Disease Treatment Product
Table 94. Valerion Therapeutics Revenue in Pompe Disease Treatment Business (2016-2021) & (US$ Million)
Table 95. Valerion Therapeutics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pompe Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Infantile-Onset Pompe Disease Features
Figure 3. Adult-Onset Pompe Disease Features
Figure 4. Global Pompe Disease Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Medical Center Case Studies
Figure 7. Other Case Studies
Figure 8. Pompe Disease Treatment Report Years Considered
Figure 9. Global Pompe Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Pompe Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pompe Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Pompe Disease Treatment Market Share by Regions (2022-2027)
Figure 13. Global Pompe Disease Treatment Market Share by Players in 2020
Figure 14. Global Top Pompe Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pompe Disease Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Pompe Disease Treatment Revenue in 2020
Figure 16. Global Pompe Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Pompe Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Pompe Disease Treatment Market Share by Type (2016-2027)
Figure 20. North America Pompe Disease Treatment Market Share by Application (2016-2027)
Figure 21. North America Pompe Disease Treatment Market Share by Country (2016-2027)
Figure 22. United States Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pompe Disease Treatment Market Share by Type (2016-2027)
Figure 26. Europe Pompe Disease Treatment Market Share by Application (2016-2027)
Figure 27. Europe Pompe Disease Treatment Market Share by Country (2016-2027)
Figure 28. Germany Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pompe Disease Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Pompe Disease Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Pompe Disease Treatment Market Share by Region (2016-2027)
Figure 38. China Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pompe Disease Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Pompe Disease Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Pompe Disease Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pompe Disease Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Pompe Disease Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Pompe Disease Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Pompe Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Amicus Therapeutics Revenue Growth Rate in Pompe Disease Treatment Business (2016-2021)
Figure 58. Audentes Therapeutics Revenue Growth Rate in Pompe Disease Treatment Business (2016-2021)
Figure 59. Sanofi Genzyme Revenue Growth Rate in Pompe Disease Treatment Business (2016-2021)
Figure 60. EpiVax Revenue Growth Rate in Pompe Disease Treatment Business (2016-2021)
Figure 61. Oxyrane Revenue Growth Rate in Pompe Disease Treatment Business (2016-2021)
Figure 62. Sangamo BioSciences Revenue Growth Rate in Pompe Disease Treatment Business (2016-2021)
Figure 63. Valerion Therapeutics Revenue Growth Rate in Pompe Disease Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界のクッシング病治療市場規模・現状・予測（2021年-2027年）

Global Cushing’s Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1677 2021年4月 93Pages
QYResearch社発行の本調査資料では、クッシング病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、エトミデート、パシレオチド）、用途別市場規模（病院薬局、小売...

世界の希少内分泌疾患治療市場規模・現状・予測（2021年-2027年）

Global Rare Endocrine Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4938 2021年4月 97Pages
QYResearch社発行の本調査資料では、希少内分泌疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、有機化合物）、用途別市場規模（病院薬局、オンライン薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界のウィルソン病治療市場規模・現状・予測（2021年-2027年）

Global Wilson's Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z6021 2021年4月 90Pages
QYResearch社発行の本調査資料では、ウィルソン病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（D-ペニシラミン、トリエンチン、テトラチオモリブデン酸塩、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、ア...

世界のサンドホフ病治療市場規模・現状・予測（2021年-2027年）

Global Sandhoff Disease Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5108 2021年4月 92Pages
QYResearch社発行の本調査資料では、サンドホフ病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ALD-601、CCP-010、DUOC-01、MTf-HEXB、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規...

世界の鎌状赤血球症治療市場規模・現状・予測（2021年-2027年）

Global Sickle Cell Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5231 2021年4月 92Pages
QYResearch社発行の本調査資料では、鎌状赤血球症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（鎌状赤血球貧血、シックルベータサラセミア、シックルヘモグロビンC病）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、...

世界の多発性嚢胞腎治療市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4689 2021年4月 99Pages
QYResearch社発行の本調査資料では、多発性嚢胞腎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（診療所、研究センター、病院）、主要地域別市場規模（北米、アメリカ、ヨー...

世界のクラッベ病治療市場規模・現状・予測（2021年-2027年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3334 2021年4月 92Pages
QYResearch社発行の本調査資料では、クラッベ病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗けいれん薬、筋弛緩薬、HSCT（造血幹細胞移植）、その他）、用途別市場規模（病院、ASC）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年）

Global Inflammatory Bowel Disease Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3161 2021年4月 94Pages
QYResearch社発行の本調査資料では、炎症性腸疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症生物製剤、非ステロイド性抗炎症薬（NSAID）、コルチコステロイド）、用途別市場規模（病院用、家庭用）、主要地域別市場規模（北米、...

世界の非アルコール性脂肪肝疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4156 2021年4月 90Pages
QYResearch社発行の本調査資料では、非アルコール性脂肪肝疾患治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界のアルツハイマー病治療市場規模・現状・予測（2021年-2027年）

Global Alzheimers Disease Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0279 2021年4月 98Pages
QYResearch社発行の本調査資料では、アルツハイマー病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（バイオマーカー、コリンエステラーゼ阻害剤、NMDA受容体拮抗薬）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメ...

世界のクラッベ病治療市場規模・現状・予測（2021年-2027年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
世界の髄膜炎菌性疾患治療市場規模・現状・予測（2021年-2027年） Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant …
世界のクッシング病治療市場規模・現状・予測（2021年-2027年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
世界のニューカッスル病治療市場規模・現状・予測（2021年-2027年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…
世界のレイノー病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Raynauds Disease Treatment Market The global Raynauds Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …